EMCC European Monitoring Centre on Change

Polyplus Transfection

Company/Organisation:
Polyplus Transfection

Geographic Location

Country: France
Region: Bas-Rhin; Alsace; Est
Location of affected unit(s): Illkirch-Graffenstaden

Company

Sector: Professional services
Scientific research and development
72.11 - Research and experimental development on biotechnology
Number Employed: 40

Employment Effects

Announcement Date: 19-06-2020
Type of Restructuring: Business expansion
Employment Effect Start: 01-07-2020
Foreseen End Date: 30-06-2023
Planned Job Creation: 100

Additional Information

Polyplus Transfection, a company specialised in the transfer of genetic material into human cells, has invested in a new production site and plans to recruit 100 employees within three years. This investment of €30 million in three years will enable it to expand from a site of a few hundred to 4,000 sqm. The aim is to keep pace with the growth in turnover, which has increased by 70% a year over the last five years. The work, started in the spring of 2020, will allow a first move in the summer of 2021 and will be completed in 2023 with the delivery of a new factory. This investment will increase Polyplus' production capacity tenfold. 

Sources: